Clvs1/2 Antikörper (C-Term)
Clvs1/2
Reaktivität: Human, Maus, Ratte
IF, WB
Wirt: Kaninchen
Polyclonal
unconjugated
1 image
-
- Target
- Clvs1/2 (Clavesin 1/2 (Clvs1/2))
- Bindungsspezifität
- C-Term
- Reaktivität
- Human, Maus, Ratte
- Wirt
- Kaninchen
- Klonalität
- Polyklonal
- Applikation
- Immunofluorescence (IF), Western Blotting (WB)
- Spezifität
- Specific for the ~35 kDa Clavesin 1/2 protein doublet in Western blots of Rat brain lysate. Isoform-specific knock down in cultured hippocampal neurons indicates that the lower and upper bands are Clavesin 1 and 2, respectively.
- Kreuzreaktivität (Details)
-
Species reactivity (expected):Human and Mouse.
Species reactivity (tested):Rat. - Aufreinigung
- Affinity Chromatography.
- Immunogen
- Synthetic peptide KLH-conjugated corresponding to amino acid residues from the C-terminal region of Rat Clavesin-1. Genename: CLVS1/2
- Isotyp
- IgG
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS containing 50 % Glycerol.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store the antibody undiluted (in aliquots) at -20 °C.
-
- Target
- Clvs1/2 (Clavesin 1/2 (Clvs1/2))
- Hintergrund
- Clavesin (clathrin vesicle associated Sec14 protein) is a novel neuron specific protein that has recently been identified and shown to be required for normal morphology of late endosomes and/or lysosomes as lentiviral-mediated knockdown of clavesin in hippocampal neurons causes lysosomal defects (Katoh et al., 2009). Additionally, upregulation of clavesin in human hepatocellular carcinoma has recently been demonstrated thus making it a useful marker for this disease state (Zhao et al., 2008).Synonyms: C6orf212, C6orf213, CLVS1, CLVS2, CRALBPL, Cellular retinaldehyde-binding protein-like, RLBP1L1, RLBP1L2, Retinaldehyde-binding protein 1-like 1/2
- Gen-ID
- 366311
- NCBI Accession
- NP_001102439
-
Sie sind hier:
